Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Microfluidics | 7 | 2022 | 651 | 2.400 |
Why?
|
Lab-On-A-Chip Devices | 3 | 2021 | 432 | 1.070 |
Why?
|
Microfluidic Analytical Techniques | 3 | 2019 | 799 | 0.860 |
Why?
|
Prostatic Neoplasms | 30 | 2021 | 11101 | 0.760 |
Why?
|
MicroRNAs | 8 | 2021 | 3758 | 0.750 |
Why?
|
Neoplasms, Hormone-Dependent | 6 | 2016 | 410 | 0.650 |
Why?
|
Acrylates | 1 | 2019 | 75 | 0.650 |
Why?
|
Transistors, Electronic | 1 | 2019 | 22 | 0.650 |
Why?
|
Colorimetry | 1 | 2019 | 149 | 0.650 |
Why?
|
Neoplastic Cells, Circulating | 4 | 2019 | 943 | 0.630 |
Why?
|
Receptors, Androgen | 9 | 2020 | 1077 | 0.620 |
Why?
|
Nucleic Acids | 1 | 2021 | 186 | 0.610 |
Why?
|
Viruses | 1 | 2019 | 372 | 0.510 |
Why?
|
Carcinoma, Renal Cell | 7 | 2024 | 3163 | 0.460 |
Why?
|
Hydrogels | 1 | 2019 | 720 | 0.440 |
Why?
|
Polyethylene Glycols | 1 | 2019 | 1187 | 0.430 |
Why?
|
Bacteria | 2 | 2020 | 2190 | 0.390 |
Why?
|
Androgen Antagonists | 7 | 2021 | 1408 | 0.390 |
Why?
|
Organic Anion Transporters | 4 | 2017 | 101 | 0.380 |
Why?
|
Kidney Neoplasms | 5 | 2024 | 4251 | 0.320 |
Why?
|
Glucuronosyltransferase | 1 | 2008 | 132 | 0.290 |
Why?
|
Polymorphism, Single Nucleotide | 12 | 2021 | 15920 | 0.280 |
Why?
|
Antineoplastic Agents, Hormonal | 4 | 2016 | 1520 | 0.270 |
Why?
|
Sepsis | 1 | 2020 | 2585 | 0.270 |
Why?
|
Kallikreins | 3 | 2016 | 220 | 0.260 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 7407 | 0.250 |
Why?
|
Genetic Association Studies | 4 | 2021 | 2731 | 0.250 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2022 | 3777 | 0.220 |
Why?
|
Selenium | 2 | 2016 | 416 | 0.210 |
Why?
|
Cell Line, Tumor | 11 | 2021 | 16952 | 0.200 |
Why?
|
Chromosomes, Human, X | 1 | 2024 | 320 | 0.200 |
Why?
|
Protein Kinases | 1 | 2009 | 1607 | 0.200 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2024 | 316 | 0.200 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2024 | 8530 | 0.190 |
Why?
|
Immunomagnetic Separation | 1 | 2021 | 79 | 0.190 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2016 | 294 | 0.190 |
Why?
|
Arthroplasty, Replacement, Knee | 3 | 2011 | 1394 | 0.190 |
Why?
|
Anterior Cruciate Ligament | 1 | 2005 | 423 | 0.190 |
Why?
|
Epigenomics | 2 | 2024 | 944 | 0.180 |
Why?
|
Prostate-Specific Antigen | 5 | 2017 | 2465 | 0.170 |
Why?
|
p300-CBP Transcription Factors | 1 | 2021 | 150 | 0.170 |
Why?
|
Antineoplastic Agents | 4 | 2019 | 13632 | 0.170 |
Why?
|
Gram-Positive Bacteria | 1 | 2020 | 176 | 0.170 |
Why?
|
Arthritis | 1 | 2005 | 681 | 0.160 |
Why?
|
Electrophoresis | 1 | 2019 | 225 | 0.160 |
Why?
|
Photochemical Processes | 1 | 2019 | 86 | 0.160 |
Why?
|
Androgens | 4 | 2016 | 1283 | 0.160 |
Why?
|
Gram-Negative Bacteria | 1 | 2020 | 271 | 0.160 |
Why?
|
DNA Methylation | 3 | 2024 | 4384 | 0.160 |
Why?
|
Rhabdoid Tumor | 1 | 2021 | 210 | 0.160 |
Why?
|
Translocation, Genetic | 1 | 2024 | 1391 | 0.160 |
Why?
|
Genetic Variation | 4 | 2018 | 6567 | 0.150 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2021 | 501 | 0.150 |
Why?
|
Phenylthiohydantoin | 2 | 2017 | 205 | 0.150 |
Why?
|
Hydrodynamics | 1 | 2019 | 168 | 0.150 |
Why?
|
Etoposide | 1 | 2019 | 635 | 0.150 |
Why?
|
Biological Transport | 3 | 2017 | 2080 | 0.140 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2011 | 550 | 0.140 |
Why?
|
Aptamers, Nucleotide | 1 | 2019 | 164 | 0.140 |
Why?
|
Orchiectomy | 4 | 2012 | 463 | 0.140 |
Why?
|
Particle Size | 2 | 2019 | 1649 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 830 | 0.140 |
Why?
|
Humans | 53 | 2024 | 761208 | 0.130 |
Why?
|
Thermodynamics | 1 | 2018 | 590 | 0.130 |
Why?
|
Taxoids | 2 | 2017 | 668 | 0.130 |
Why?
|
Promoter Regions, Genetic | 3 | 2021 | 5773 | 0.130 |
Why?
|
Surface Properties | 1 | 2019 | 1162 | 0.130 |
Why?
|
Early Diagnosis | 1 | 2020 | 1186 | 0.130 |
Why?
|
Microbial Sensitivity Tests | 1 | 2021 | 1936 | 0.120 |
Why?
|
RNA, Messenger | 3 | 2019 | 12747 | 0.120 |
Why?
|
Fluorouracil | 1 | 2019 | 1642 | 0.110 |
Why?
|
Ultraviolet Rays | 1 | 2019 | 1078 | 0.110 |
Why?
|
Anoikis | 1 | 2014 | 50 | 0.110 |
Why?
|
Androstenes | 1 | 2015 | 181 | 0.110 |
Why?
|
Cell Communication | 1 | 2021 | 1651 | 0.110 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 593 | 0.110 |
Why?
|
RNA, Neoplasm | 1 | 2016 | 748 | 0.110 |
Why?
|
Diathermy | 1 | 2013 | 17 | 0.110 |
Why?
|
Histone Demethylases | 1 | 2016 | 322 | 0.110 |
Why?
|
Ion Channels | 1 | 2018 | 1038 | 0.110 |
Why?
|
Receptor, IGF Type 1 | 1 | 2015 | 380 | 0.110 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15520 | 0.100 |
Why?
|
Anilides | 1 | 2015 | 411 | 0.100 |
Why?
|
Hemostatic Techniques | 1 | 2013 | 111 | 0.100 |
Why?
|
Estradiol Dehydrogenases | 1 | 2011 | 16 | 0.100 |
Why?
|
Neoplasm Invasiveness | 3 | 2016 | 3590 | 0.100 |
Why?
|
Biosensing Techniques | 1 | 2018 | 647 | 0.100 |
Why?
|
DNA Repair | 1 | 2021 | 2041 | 0.100 |
Why?
|
Vitamin E | 1 | 2016 | 872 | 0.100 |
Why?
|
Organic Anion Transporters, Sodium-Independent | 1 | 2011 | 28 | 0.100 |
Why?
|
Tantalum | 1 | 2011 | 54 | 0.090 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 3245 | 0.090 |
Why?
|
Renal Artery | 1 | 2013 | 351 | 0.090 |
Why?
|
Prognosis | 5 | 2022 | 29687 | 0.090 |
Why?
|
DNA Damage | 1 | 2021 | 2442 | 0.090 |
Why?
|
Dihydrotestosterone | 2 | 2009 | 195 | 0.090 |
Why?
|
Nephrectomy | 2 | 2013 | 938 | 0.090 |
Why?
|
Male | 39 | 2024 | 360693 | 0.090 |
Why?
|
Adenocarcinoma | 3 | 2016 | 6341 | 0.090 |
Why?
|
Toll-Like Receptor 9 | 1 | 2011 | 193 | 0.090 |
Why?
|
Disease Progression | 8 | 2020 | 13511 | 0.090 |
Why?
|
Lipids | 1 | 2021 | 3331 | 0.090 |
Why?
|
NF-kappa B | 2 | 2016 | 2475 | 0.090 |
Why?
|
Estrogen Receptor beta | 1 | 2010 | 169 | 0.080 |
Why?
|
Dehydroepiandrosterone Sulfate | 3 | 2015 | 241 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2021 | 5300 | 0.080 |
Why?
|
DNA | 2 | 2020 | 7189 | 0.080 |
Why?
|
Escherichia coli | 1 | 2021 | 4201 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2012 | 566 | 0.080 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 2011 | 1146 | 0.080 |
Why?
|
Knee Prosthesis | 1 | 2011 | 395 | 0.080 |
Why?
|
Nanotechnology | 1 | 2014 | 713 | 0.080 |
Why?
|
RNA Interference | 3 | 2015 | 2816 | 0.070 |
Why?
|
Gold | 1 | 2011 | 482 | 0.070 |
Why?
|
Genotype | 8 | 2016 | 12985 | 0.070 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2009 | 418 | 0.070 |
Why?
|
Gonadal Steroid Hormones | 1 | 2011 | 702 | 0.070 |
Why?
|
Metal Nanoparticles | 1 | 2011 | 400 | 0.070 |
Why?
|
Androgen Receptor Antagonists | 1 | 2008 | 125 | 0.070 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1360 | 0.070 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2009 | 452 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2021 | 3634 | 0.070 |
Why?
|
Cohort Studies | 12 | 2021 | 41496 | 0.070 |
Why?
|
Microchemistry | 1 | 2006 | 54 | 0.070 |
Why?
|
Blood Transfusion, Autologous | 1 | 2006 | 130 | 0.070 |
Why?
|
Estrogen Receptor alpha | 1 | 2010 | 582 | 0.070 |
Why?
|
Phagocytosis | 1 | 2011 | 1525 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3198 | 0.060 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 1743 | 0.060 |
Why?
|
Middle Aged | 22 | 2024 | 220853 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4567 | 0.060 |
Why?
|
Testosterone | 3 | 2011 | 2472 | 0.060 |
Why?
|
Dengue Virus | 1 | 2006 | 201 | 0.060 |
Why?
|
Aged | 19 | 2021 | 169288 | 0.060 |
Why?
|
Prosthesis Design | 1 | 2011 | 2114 | 0.060 |
Why?
|
Ischemia | 1 | 2013 | 1889 | 0.060 |
Why?
|
Prostatectomy | 3 | 2021 | 1825 | 0.060 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2020 | 790 | 0.060 |
Why?
|
Immunoprecipitation | 2 | 2016 | 874 | 0.060 |
Why?
|
Hematinics | 1 | 2006 | 282 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 1168 | 0.050 |
Why?
|
Pyridines | 1 | 2015 | 2872 | 0.050 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2021 | 455 | 0.050 |
Why?
|
Cell Line | 4 | 2020 | 15545 | 0.050 |
Why?
|
Haplotypes | 2 | 2024 | 2715 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 6 | 2016 | 17897 | 0.050 |
Why?
|
Germ Cells | 2 | 2021 | 632 | 0.050 |
Why?
|
Signal Transduction | 6 | 2021 | 23416 | 0.050 |
Why?
|
Knee Joint | 1 | 2011 | 1678 | 0.050 |
Why?
|
Adiponectin | 1 | 2008 | 1107 | 0.050 |
Why?
|
RNA | 1 | 2012 | 2709 | 0.050 |
Why?
|
Blood Loss, Surgical | 1 | 2006 | 637 | 0.050 |
Why?
|
Erythropoietin | 1 | 2006 | 719 | 0.050 |
Why?
|
Mutation | 3 | 2022 | 30002 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3594 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12676 | 0.050 |
Why?
|
Nitriles | 2 | 2017 | 971 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2024 | 582 | 0.050 |
Why?
|
Estradiol | 1 | 2008 | 1937 | 0.050 |
Why?
|
Phosphorylation | 3 | 2021 | 8300 | 0.050 |
Why?
|
Laparoscopy | 1 | 2013 | 2035 | 0.050 |
Why?
|
Benzamides | 2 | 2017 | 1371 | 0.050 |
Why?
|
Down-Regulation | 1 | 2008 | 2916 | 0.050 |
Why?
|
Proportional Hazards Models | 4 | 2016 | 12474 | 0.040 |
Why?
|
Neoplasms | 1 | 2009 | 22140 | 0.040 |
Why?
|
Aged, 80 and over | 8 | 2021 | 58952 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2915 | 0.040 |
Why?
|
Cell Proliferation | 4 | 2016 | 10422 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 164 | 0.040 |
Why?
|
Survival Rate | 4 | 2018 | 12728 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9278 | 0.040 |
Why?
|
Preoperative Care | 2 | 2006 | 2241 | 0.040 |
Why?
|
Prostate | 2 | 2020 | 1772 | 0.040 |
Why?
|
Carcinoma | 1 | 2010 | 2330 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2016 | 6486 | 0.040 |
Why?
|
Gene Expression | 2 | 2009 | 7571 | 0.040 |
Why?
|
Risk Factors | 9 | 2016 | 74239 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 6919 | 0.040 |
Why?
|
RNA, Viral | 1 | 2006 | 2839 | 0.040 |
Why?
|
Genes, BRCA2 | 1 | 2021 | 591 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 697 | 0.040 |
Why?
|
Kidney | 1 | 2013 | 7033 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2021 | 7571 | 0.040 |
Why?
|
Macrophages | 1 | 2011 | 5753 | 0.030 |
Why?
|
Plasma | 1 | 2020 | 586 | 0.030 |
Why?
|
Electrons | 1 | 2018 | 265 | 0.030 |
Why?
|
Tristetraprolin | 1 | 2016 | 38 | 0.030 |
Why?
|
Steroid 17-alpha-Hydroxylase | 1 | 2016 | 99 | 0.030 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.030 |
Why?
|
Thioredoxin Reductase 1 | 1 | 2016 | 32 | 0.030 |
Why?
|
Selenium-Binding Proteins | 1 | 2016 | 18 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2024 | 1605 | 0.030 |
Why?
|
Drug Antagonism | 1 | 2015 | 51 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39126 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2021 | 987 | 0.030 |
Why?
|
Prospective Studies | 6 | 2012 | 54435 | 0.030 |
Why?
|
Glutathione Peroxidase | 1 | 2016 | 258 | 0.030 |
Why?
|
Tissue Kallikreins | 1 | 2014 | 14 | 0.030 |
Why?
|
Transfection | 2 | 2015 | 5748 | 0.030 |
Why?
|
Survival Analysis | 2 | 2021 | 10088 | 0.030 |
Why?
|
Mediator Complex Subunit 1 | 1 | 2014 | 30 | 0.030 |
Why?
|
Female | 7 | 2024 | 392544 | 0.030 |
Why?
|
Selenoproteins | 1 | 2016 | 215 | 0.030 |
Why?
|
Retrospective Studies | 7 | 2021 | 80674 | 0.030 |
Why?
|
Binding, Competitive | 1 | 2015 | 1140 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2640 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2016 | 848 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1756 | 0.030 |
Why?
|
Introns | 1 | 2015 | 968 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1852 | 0.030 |
Why?
|
Castration | 1 | 2012 | 150 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9416 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2023 | 3493 | 0.030 |
Why?
|
COS Cells | 1 | 2014 | 1129 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2016 | 1695 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1602 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2014 | 419 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4243 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3788 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2021 | 2803 | 0.020 |
Why?
|
Phagosomes | 1 | 2011 | 199 | 0.020 |
Why?
|
HMGB1 Protein | 1 | 2011 | 136 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2011 | 704 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 4739 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2827 | 0.020 |
Why?
|
Bone Cements | 1 | 2011 | 325 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1892 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2016 | 1741 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3418 | 0.020 |
Why?
|
Time Factors | 3 | 2017 | 39957 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5032 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6124 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2009 | 382 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 367 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2014 | 1749 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2016 | 2329 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1624 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1495 | 0.020 |
Why?
|
Arthralgia | 1 | 2011 | 461 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1743 | 0.020 |
Why?
|
Adult | 6 | 2021 | 221119 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2016 | 2444 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3592 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2011 | 790 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2024 | 11509 | 0.020 |
Why?
|
Epoetin Alfa | 1 | 2006 | 78 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2635 | 0.020 |
Why?
|
Lysosomes | 1 | 2011 | 921 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2011 | 1204 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2897 | 0.020 |
Why?
|
Genetics, Population | 1 | 2010 | 935 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2011 | 11119 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 22174 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18220 | 0.010 |
Why?
|
Range of Motion, Articular | 1 | 2011 | 1590 | 0.010 |
Why?
|
Computational Biology | 1 | 2016 | 3499 | 0.010 |
Why?
|
Cell Survival | 1 | 2014 | 5778 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2016 | 64681 | 0.010 |
Why?
|
Swine | 1 | 2013 | 5909 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4107 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2013 | 2092 | 0.010 |
Why?
|
Incidence | 2 | 2011 | 21365 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12052 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6067 | 0.010 |
Why?
|
Alleles | 1 | 2012 | 6857 | 0.010 |
Why?
|
Animals | 4 | 2015 | 168079 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3803 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2011 | 6819 | 0.010 |
Why?
|
Hemoglobins | 1 | 2006 | 1525 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4340 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 6974 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9477 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2017 | 4822 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9457 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10756 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3446 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2010 | 4513 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6504 | 0.010 |
Why?
|
Biopsy | 1 | 2008 | 6781 | 0.010 |
Why?
|
Mice | 2 | 2015 | 81326 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5782 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18384 | 0.010 |
Why?
|
Logistic Models | 1 | 2008 | 13249 | 0.010 |
Why?
|
Inflammation | 1 | 2012 | 10759 | 0.010 |
Why?
|
United States | 1 | 2017 | 72339 | 0.010 |
Why?
|
Obesity | 1 | 2008 | 12939 | 0.000 |
Why?
|